rs367573665
Variant names:
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_198271.5(LMOD3):c.1428G>A(p.Pro476Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,611,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000073 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000066 ( 0 hom. )
Consequence
LMOD3
NM_198271.5 synonymous
NM_198271.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.80
Publications
1 publications found
Genes affected
LMOD3 (HGNC:6649): (leiomodin 3) The protein encoded by this gene is a member of the leiomodin family of proteins. This protein contains three actin-binding domains, a tropomyosin domain, a leucine-rich repeat domain, and a Wiskott-Aldrich syndrome protein homology 2 domain (WH2). Localization of this protein to the pointed ends of thin filaments has been observed, and there is evidence that this protein acts as a catalyst of actin nucleation, and is important to the organization of sarcomeric thin filaments in skeletal muscles. Mutations in this gene have been associated as one cause of Nemaline myopathy, as other genes have also been linked to this disorder. Nemaline myopathy is a disorder characterized by nonprogressive generalized muscle weakness and protein inclusions (nemaline bodies) in skeletal myofibers. Patients with mutations in this gene often present with a severe congenital form of the disorder. [provided by RefSeq, Jan 2015]
LMOD3 Gene-Disease associations (from GenCC):
- nemaline myopathy 10Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 3-69118927-C-T is Benign according to our data. Variant chr3-69118927-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 475305.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.8 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LMOD3 | ENST00000420581.7 | c.1428G>A | p.Pro476Pro | synonymous_variant | Exon 2 of 3 | 1 | NM_198271.5 | ENSP00000414670.3 | ||
| LMOD3 | ENST00000475434.1 | c.1428G>A | p.Pro476Pro | synonymous_variant | Exon 3 of 4 | 5 | ENSP00000418645.1 | |||
| LMOD3 | ENST00000489031.5 | c.1428G>A | p.Pro476Pro | synonymous_variant | Exon 3 of 4 | 2 | ENSP00000417210.1 |
Frequencies
GnomAD3 genomes AF: 0.0000733 AC: 11AN: 150120Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
11
AN:
150120
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000603 AC: 15AN: 248612 AF XY: 0.0000742 show subpopulations
GnomAD2 exomes
AF:
AC:
15
AN:
248612
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461644Hom.: 0 Cov.: 33 AF XY: 0.0000715 AC XY: 52AN XY: 727108 show subpopulations
GnomAD4 exome
AF:
AC:
96
AN:
1461644
Hom.:
Cov.:
33
AF XY:
AC XY:
52
AN XY:
727108
show subpopulations
African (AFR)
AF:
AC:
1
AN:
33480
American (AMR)
AF:
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39662
South Asian (SAS)
AF:
AC:
7
AN:
86250
European-Finnish (FIN)
AF:
AC:
1
AN:
53396
Middle Eastern (MID)
AF:
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
86
AN:
1111858
Other (OTH)
AF:
AC:
1
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000733 AC: 11AN: 150120Hom.: 0 Cov.: 30 AF XY: 0.0000410 AC XY: 3AN XY: 73100 show subpopulations
GnomAD4 genome
AF:
AC:
11
AN:
150120
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
73100
show subpopulations
African (AFR)
AF:
AC:
1
AN:
40626
American (AMR)
AF:
AC:
1
AN:
14940
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5144
South Asian (SAS)
AF:
AC:
0
AN:
4620
European-Finnish (FIN)
AF:
AC:
0
AN:
10366
Middle Eastern (MID)
AF:
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
AC:
9
AN:
67690
Other (OTH)
AF:
AC:
0
AN:
2048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nemaline myopathy 10 Benign:1
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.